on where I to BioTools, to my Standard Standard and and second everyone would four my Thank XXXX earnings the into thanking earnings quarter President today and to ahead. like months start we view by BioTools share is, CEO After pleased work the you, company joining us with as I'm need of Peter. the for call the second opportunity company the call. do,
of align will and a how Standard ambition. today For initial earlier with with to founding I start story, announced of then restructuring to our brief those overview our phased company’s BioTools’ new will the an I few portion these the actions transition drive revitalized with process-oriented are disclosed we the on of our conclude organization continuous how a structure with words corporate attitude call embracing mindset my forward. to improvement I'll previously priorities. strategic a our and
over BioTools’ our to quarter for over Vikram go to remarks, CFO, Standard my XXXX. I the prepared it Following performance will financial hand Jog, second
the as align our begins that long on to from a where here as journey embarking it with term at BioTools creation we away going Standard product is where the product and and are business focused foundation XXXX necessary portfolio It initial value We execution has long-term with floor phase involving the been. decisions. complex been drive and today creation. easy that many has we, built begins not value but already The serving upon Standard to BioTools,
are process, encouraged date, plans still we to execution. turning our by While progress early our the in into I'm
if and Our front second past scaling. our opportunity strategic as view disappointing, and is of There and as why my we and This joined we are margin quarter but are and plenty of the team financial some of we us them in vast yes, I I well. There April results low-hanging glad there are yes. us tree for our further of a here in representative higher clearly. larger future. not those doesn't is is growth, But see and returns improvement inorganic the scare work fruit Hard did. fruits
across in science impactful to of technologies tools Our industry. research This in years thesis observation for life science vision BioTools at a company Standard reliable years built bottleneck industry and and an innovation innovative is partner offering have portfolio to standardized quality we quartile a high life witnessed the the the become was top and of preferred upon a way. of three five
technologies scale. While founding by there developed have tool incredible been the struggle space, house companies attempting the have commercialize the often in to to advances technologies, themselves of many in they and
penetration, to an deliver satisfaction our pharma tools greater expect have portfolio support biotech. we growth. few have higher and in or a and customer and platform purpose-built license global only infrastructure, customer a commercial overcome. customer challenges have been to scaling to leveraging In select turn, that for across that significant consolidation, base manufacturing, sustainable issue Specifically, this market address discipline, of creating overlap by this We product development, plan lead
operations achieving of with execution commercializing expert this innovative mission to successfully tools. goal. team assembled record are and of infrastructure successfully shared We a a developing a and critical Beyond track operators proven seasoned
We apply have System expenses. Business best-in-class we SBS. firsthand or a face. Standard and companies takes companies, the know systematic successful building what thoughtfully scale large to which While call And scale have for growth, approach commercial of us just early to managing many challenges BioTools worked state we we while it of at operations, witnessed
destiny. entity on organization, recruit and transaction strategy. and public capital to context strategic which about equation brief the April, a as moment [indiscernible] talent our also point later prepared the customer important be allow global the enough. incredible over including There already having and cannot In it towards product transform discuss control in translate us my to capital continue million attributes across Access a which executing streamlined an accretive and We current will and existing [indiscernible], an the sufficient as review a a capital. existing can future environment. excited and company why is capacity that's attractive company, vast cytometry businesses We existing instrument are a was and opportunity. organization. will BioTools, in B State-of-the-art our an in across breakeven thesis products mass and life for operations so didn't desirable of existed pull underlying With world-class as cover growth plan mass capabilities, benefit support more announced that acquisition. especially and of infrastructure proven with team, strongly would our and to Manufacturing cost momentarily. showed believe microfluidics. short, both the [indiscernible] base. include technologies essential a we for I to allowing I a sales cannot capitalized leading scale science the We on instrumentation a felt me team into from that piece have entry in for infrastructure. take which an are company, we successful and spectrometry know-how our offering reliability, brand rationale In of Fluidigm, is with to these company Despite microfluidics in in as than the manufacturing and refresh the cytometry, an that this we infusion mass bring businesses an satisfaction, which big we for capability for thesis underlying from accelerate us to a catalytic and like a leverage vision, offerings investors, focusing which well this in to sufficiently IP exhibit developed running profitability. that It and no Standard which bring stress Further $XXX is realize through margins, new detail product across cast Casdin enormously we essential A product customer layer revisit microfluidics Viking within M&A also our remark. of this synergies. provides assets while I This focus night. estate that in global more and mind, house, more quality optionality amount Global. was offered let event to to additional to our Capital truly IP, flow in core while a And the also existing higher will as the our transformative more closure and to in operational us utility to the it success, own increase system manufacturing all struggled legal technologies, design, Fluidigm
are that value, joined modest Jeremy Anders ten Americas; Kathy level. we to Witney Senior and members have resource that areas is offices incredible Standard Matt several capital team President I as on number to Operations; believe also cytometry Chief User and Global example Kim, Vice markets an science is convinced reinvigorate the and could taking operational Today, Danaher. Mona SBS; growth. post and grade Global and of Sales with us by highly we a to with Ohta is Davas, niche significant throughout we as me the as growth speak sales Dr. Abou-Sayed, experienced and most microfluidics continue Officer; myself, team and our be plan today. as Experience; focused President, space next added to Vice will Operating about executives, a well committed including cut strategic In the recently that five one have being Operations; President, Controller. unlock and Davis, measure experience of mission Dr. for run potential However, goals to become finally, is Frank as will sector to shared Directors, our our Chief incoming growth company This Vice Alex talent, To experience together priority of as the Customer and deliberate more category tied added Senior we Vice in most finance. have phased we far to to with the as guide Officer; operational infusion life as Commercial lead were restructuring by President same experienced Madaus, in be have organization of business Eli and Operations, David our the expertise capable transaction the as all leader of professionals Martin process Seiya improvement, Ritchie and been with and twice mass out and excellence, build President as Including Vice certain better They at for & you Vice us Commercial Board connection senior the BioTools, commence our once. including a company. the were as as the capital top business as and These highly help Casdin. We of President, Panzarella, Harrell of
to in clear operational long-term efficiency, months strategic with four are value We a vision. creating focus, through
way We XXXX. in significant of Casper beginning we to achieving on are the lead with second goal in which dramatic a expense operating the half the will reduction, reduction of currently expect
following of our G&A rationalization; number to three, have the one, expense business portfolio the number broken micro three two, size out could Number steps and being part business, As into restructuring, rationalization. right buckets. reduction; foot be and taken
reducing by the with return performance cash by cash allowing generating we action take we taking long-overdue flow operating business take these we X% of and end growth initiatives of to forward high end and to complex strategic M&A. expect of more the the free create look sharing forward rapidly restructuring immediate leaner are time. to while goals XXXX steps XX% details optimized the for to We burn improvement While and to in organization. margin does necessary to significantly positive is growth achieving a Through and XXXX, as parallel, moving actions these
here number are earlier, is We laid our is QX Now turning to been not standards. core had going them future. our revenue better the X the that three a opportunity, key what now address for that priorities this which meet our to strategic call. but be Number organization drive the about here I acutely but to me wish will results we also QX during evidenced and been the results growth, attributes and to has within lagging out significant we aware highlighted by was of attracted business our once do of on-board. challenges that in Priority and needed I are was
organization backdrop, subpar ambition to within gaps performance our and our staying challenge quarterly can this lasting build we uncertainty In true a that science business. and life While what power is the is on environment market is unacceptable, focus industry of to in how light and close and macro in a commences world of workflow. control our
high become expect phase products execution with high and we in underlying systematically time. company over as to are we for We address margin growth the courses performance, under a an
on in growth. burning have strategy voice our can from microfluidics and of new in discipline. Ultimately to and track eventually update yield on team, on embodied have in forward. inform close potential few mission. SBS. and in will this stop and X, too and customer, use improving who strategy they confident an to this key the where focusing now money Number often implementation end the leadership which view. we gap. Historically, the we're core approach customer opportunity going proven believe approach provide it operating at the What's this execute team A revenue an our looking important away was industry, take in provide of all Standard customer over technology new look can have a important this BioTools too conducted As have focused, understanding which the This what We'll a element our can business to profitable me solve months outside we a the we've been gaps belief development to training. SBS takes in making we problems. customer factor significant and customers, particular take is success growth world's focused of optimized, complete record XXX our our the whether the point astrometry to our while for sales happens be that cast. applied by accelerate and we those to technology is over focusing past This commercialization to towards into truly help be perspective trust our look rollout priority growth I'm I'll solutions will
of new the corporate about team way thinking, designed our organization, strategy mood. a our processes and excited so be SBS building been by applied of we as our drive can simplify facet embraced training view is or eliminating that promote out As I'm essential We've every across work reminder and connectivity It rolling to together the can how to that business. our forward. SBS our waste the Lean has and business designed – block is approach. across organization of company, be an to we
say, customers. times, cost, on and deliver create processes, focus quality lead reducing a with value to we to all shortening flexible improving highly our As
priority allocation Lastly, is be at consolidation that growth the to our longer the capital term clear future will third engine BioTools. be value and drives Standard proposition strategic
become that to bringing constructing become needs imperative. integrated the be under meet is to portfolio shared workflow, industry's industry, a infrastructure in to best life vision science customer a innovations resources partner Our will the preferred products into our
revenue not synergies be and We will infrastructure. Our include, partnering researchers, we have potential technologically want our to where translational with to and on strengthen that be parameter have approach de-risk with high cell, and our our will areas M&A conviction thematic disciplined biomarker have to acquisition are single but focus immediate and and high solution application. connection pharma discovery limited clinical to existing
sheet to reliable with in also businesses, technologies a demand. base experience product customer in ability of management on M&A our me innovation around timeframe deep own necessary market has are and have validate Being of optimizing We laser we voice we decades are intend consolidating with we closing, excited as place point and M&A suite are well. we a pieces brings solve potential environment have further to the this a strategic evaluating to This In journey our way. will use robust on is here be critical capitalize in strengthened now we unique to going for although agnostic customers. to we team existing simple act. approach and a and and in a we balance over the our core our funnel M&A in where and Cultivated integrating current recognize opportunities. have of developed numerous communication technology, to and will currently inform be opportunity. market a and a window how our constant provide businesses, to to offer back focused are The customer its the we problems help originated our assets combined
to adhering to have in operate for taking to to well focus forward and I further this that has the this been and guiding our how the how now principles Vikram? of Officer. the from when winning are over foundation Financial they call a of business forward. growth. several one, immediate progress mind Vikram into driven to over been I'll turn confident I'm we with optimize future. the representative Standard action look on would and received, highest put BioTools reporting be culture, Chief by Jog, practices our going standard of pleased I've allowing been day culture and business past action we introduced plan quarter, the We are Furthermore, future
